PMID: 2116565Aug 1, 1990Paper

Effects of prostacyclin on hepatic metastases from human pancreatic cancer in the nude mouse

The Journal of Surgical Research
M A SchwalkeM P Vezeridis

Abstract

Human pancreatic cancer is an aggressive malignancy, with systemic metastases ultimately accounting for its grave prognosis. Arachidonic acid metabolites known to affect platelet function also interfere with tumor growth and metastases. We evaluated the effect of prostacyclin on the hepatic metastases of a human pancreatic cancer in a nude mouse model. The mean surface area of tumor on the liver was significantly reduced in all treatment groups. In the control group 485 mm2 of tumor was present on the liver surface. Animals treated with 200 micrograms of prostacyclin 0.5 hr prior to the injection of tumor cells had 21 mm2 of tumor present on the liver surface (P = 0.004). Similarly, 400 micrograms of prostacyclin caused a reduction of tumor surface area to 20 mm2 (P = 0.004). The maximal reduction of tumor surface area, 11 mm2, was observed when 200 micrograms of prostacyclin was given 0.5 hr prior to and 4.0 hr after the injection of tumor cells (P = 0.003). For the group given 200 micrograms of prostacyclin 4.0 hr after the injection of tumor, the surface area of tumor was 85 mm2 (P = 0.017). The number of tumor colonies on the liver surface was significantly reduced from 20 to 11 when 200 micrograms of prostacyclin was admin...Continue Reading

References

Jan 1, 1990·The Journal of Surgical Research·M P VezeridisP Calabresi
Jan 1, 1985·Cancer Chemotherapy and Pharmacology·T TsuruoY Sakurai
May 1, 1973·International Journal of Cancer. Journal International Du Cancer·G J GasicS Murphy
Sep 1, 1968·Proceedings of the National Academy of Sciences of the United States of America·G J GasicC C Stewart
Jan 1, 1984·Gynecologic and Obstetric Investigation·P K Heinonen, T Metsä-Ketelä
Dec 1, 1984·World Journal of Surgery·J H Harvey, P S Schein
Dec 15, 1983·International Journal of Cancer. Journal International Du Cancer·K C Agarwal, R E Parks
Jun 12, 1981·Science·K V HonnA Skoff
Jun 5, 1981·Science·B F SloaneK V Honn
Aug 21, 1980·The New England Journal of Medicine·H Rinderknecht, I G Renner

❮ Previous
Next ❯

Citations

Dec 1, 1994·Cancer Metastasis Reviews·M R SchneiderK V Honn
Jan 16, 1999·Journal of the National Cancer Institute·M HejnaC C Zielinski
Dec 2, 2014·International Journal of Oncology·Yoshinori MinamiYoshinobu Ohsaki
Nov 1, 1994·The British Journal of Surgery·W G JiangM B Hallett
Jul 3, 2008·Nature Clinical Practice. Gastroenterology & Hepatology·Inaam A Nakchbandi, J-Matthias Löhr
Nov 1, 1996·Occupational and Environmental Medicine·M HuvinenA Aitio
Oct 9, 1998·Occupational and Environmental Medicine·E SymanskiS M Rappaport
Jan 22, 2019·Indian Journal of Critical Care Medicine : Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine·Vijoy Kumar Jha, K V Padmaprakash
Jan 1, 1991·Immunopharmacology and Immunotoxicology·M TurrizianiL De Vecchis
May 1, 1997·Medical Hypotheses·C H van Aswegen, D J du Plessis

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.